Getting Besponsa (Inotuzumab Ozogamicin) Covered by UnitedHealthcare in Georgia: Complete Prior Authorization and Appeals Guide
Answer Box: Fastest Path to Besponsa Coverage
Besponsa (inotuzumab ozogamicin) requires prior authorization from UnitedHealthcare for CD22-positive B-cell precursor ALL. Your oncologist must submit through the UnitedHealthcare Provider Portal with pathology confirming CD22 positivity, evidence of first-line therapy failure, and a hepatic monitoring plan. Standard approval takes 5-15 business days;